BURLINGAME, CA--(Marketwire - November 19, 2007) - APT Pharmaceuticals, a specialty drug development company primarily focused on inhaled treatments for serious lung diseases, announced today that it has filled two new positions on its executive team with experienced industry veterans from Genentech.
